Alimentary Pharmacology & Therapeutics

Alimentary Pharmacology & Therapeutics (Aliment Pharmacol Ther) is a leading international peer-reviewed journal dedicated to the rapid publication of high-quality clinical and experimental research in the fields of gastroenterology and hepatology. The journal’s scope encompasses the full spectrum of alimentary tract and liver disorders, with a particular emphasis on the pharmacology and therapeutic management of conditions such as inflammatory bowel disease, functional gastrointestinal disorders, peptic ulcer disease, gastrointestinal bleeding, pancreatic disease, and chronic liver disease including viral hepatitis and non-alcoholic fatty liver disease. The journal publishes a diverse range of article types, including original research articles, systematic reviews, meta-analyses, and concise clinical reports, as well as editorials and correspondence that foster critical discussion. Its target audience comprises clinical gastroenterologists, hepatologists, pharmacologists, and researchers seeking authoritative, clinically relevant evidence to inform patient care and advance therapeutic strategies. Published by Wiley, the journal offers both subscription and open access options, allowing authors to choose the dissemination model that best suits their needs. With a 2026 Impact Factor of 6.800 and consistently ranked in the JCR Q1 quartile, Alimentary Pharmacology & Therapeutics holds a distinguished position among specialty gastrointestinal journals, recognized for its rigorous peer-review process, rapid publication times, and high citation impact. Its sustained performance places it among the most influential and widely read journals in its field, making it an essential resource for practitioners and scientists committed to improving outcomes in digestive and liver diseases.